Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.74B P/E - EPS this Y 1.10% Ern Qtrly Grth -
Income -133.09M Forward P/E -69.32 EPS next Y 59.90% 50D Avg Chg 1.00%
Sales 37.28M PEG - EPS past 5Y - 200D Avg Chg 63.00%
Dividend N/A Price/Book 15.68 EPS next 5Y - 52W High Chg -
Recommedations 3.00 Quick Ratio 4.38 Shares Outstanding 71.92M 52W Low Chg 248.00%
Insider Own 12.01% ROA -18.55% Shares Float 58.98M Beta 1.23
Inst Own 84.39% ROE -46.96% Shares Shorted/Prior 7.61M/6.92M Price 51.99
Gross Margin -92.76% Profit Margin - Avg. Volume 2,578,060 Target Price 52.00
Oper. Margin -353.17% Earnings Date Feb 27 Volume 1,995,469 Change 0.00%
About ChemoCentryx, Inc.

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.

CCXI Chatroom

User Image TheGuyUnderMeSucks Posted - 1 day ago

@Ub3r5pAnK Pretty logical conclusion. I did a similar analysis to $CCXI right before hitting a 3x. Just compare it to other companies in similar scenarios to determine what the most likely outcome is.

User Image RamenLives Posted - 1 week ago

@A_Train1 $ccxi was the best investment I ever made!

User Image Ohzipit Posted - 1 week ago

With the manipulation we have seen since OW and especially today in a green market, I would say we are getting very close. Same occurred with $CCXI and more recently $CBAY leading into buyout. This smells of desperation. Shorts will be crushed!

User Image dogDazeSummer Posted - 1 week ago

Raymond James Steve Seedhouse raised price tgt $IFRX after Fridays close yesterday from $11 to $13. Reiterated Strong Buy 1 tanking. Sees Q2 2025 equity raise at $5/ share, no longer seeing dilution in Q4 2024 which clearly adds value. Cites $CCXI, later acquired for $4b by $AMGN, an equity he was also instrumental in recommending/ showcasing with Strong Buy 1 Superior to #avacopan, #vilobelimab revenue up 20x sequentially from Q2 announced yesterday. Up next InflaRX: Fireside chat this Monday w Guggenheim anyone can log in. Possible EMA decision this Friday. INF904 study / updates in 4 weeks BARDA trial pending, exact timing TBD PG data Q2 2025.

User Image RamenLives Posted - 1 week ago

$IOVA still, not as tight of a stop loss raid as the legendary $ccxi one on the night before fda approval.

User Image BlackHatCandles Posted - 2 weeks ago

$CCXI fiest ever stock i hit big on live yall my ccxi family still holds strong greatest stock ever

User Image GXD_Texas Posted - 2 weeks ago

@TAG01 love me some $CCXI 😍

User Image Cacaos Posted - 2 weeks ago

$VKTX I don’t sell the news when I’m all in, lol $ccxi🔥was my last all in bio gl all

User Image ils85 Posted - 2 weeks ago

$CCXI

User Image Grrrissom Posted - 10/29/24

$CCXI Not that I'm complaining, I rather enjoy stopping by from time to time and reminiscing the good times that led to my most profitable trade ever, but... why is this ticker even still up here anymore, never mind showing any kind of activity?? 🤔

User Image RamenLives Posted - 10/25/24

$IOVA Now just here me out... when I was in $ccxi they never officially set a earnings date right before the BO announcement... now saying that is the case here, but....

User Image MontanaT Posted - 10/22/24

$CCXI my first 6 figure sell... EDU was my second, but now ALDX. ABBVie going to take us home.

User Image mh_aina Posted - 1 month ago

$IMRX just noticed they have Dr Thomas Schall as a board member, $CCXI was my first big winner bio

User Image dogDazeSummer Posted - 1 month ago

$IFRX So we have Eculizumab (Soliris; Alexion), a C5 inhibitor bought by $AZN We have $CCXI avacopan bought by $AMGN New data out today highlighting benefits of Eculizumab in Thrombotic Microangiopathy If C5 (a) plays role in this as well, it’s a wi for all the players since they have slightly different mechanisms. Ultimately the standard of care will be Vilo + X as PANAMO study supports. Room for many player in multiple $b modalities. https://www.pharmacytimes.com/view/eculizumab-and-other-therapies-for-the-treatment-of-high-risk-transplant-associated-thrombotic-microangiopathy

User Image Kingjake26 Posted - 1 month ago

I seriously believe that large pharmaceutical companies are looking at us. This feels better then $CCXI Just saying.

User Image Kingjake26 Posted - 2 months ago

@PLATINUM_TRADES @IC1101 it’s not a dream And for your information I made enough to retire on with $CCXI and $MYOV buyouts. A Japan company both them out. It’s a blessing to do research and not trade all Day trying to make a few bucks while paying a crap ton to do taxes and paying federal and state taxes. I like my long term gains at only 15% tax.

User Image Kingjake26 Posted - 2 months ago

$CAPR $XBI @Stocktor You helped me out with $CCXI and $VRNA Here is one for you.

User Image Kingjake26 Posted - 2 months ago

Look who is on the list. $CCXI That was bought out. :)))

User Image RamenLives Posted - 2 months ago

$CCXI

User Image NVDAMillionaire Posted - 3 months ago

$CCXI ChemoCentryx, Inc. (NASDAQ:CCXI): A Promising Biopharmaceutical Company Navigating Challenges http://beyondspx.com/2024/08/05/chemocentryx-inc-nasdaqccxi-a-promising-biopharmaceutical-company-navigating-challenges/

User Image Larrygor Posted - 4 months ago

$BLUE get a run like $SMMT and $HUMA or BO like $PRVB or $CCXI Bluebird could be a major player in Gene therapy with many QTCs opened and patients are enrolling! only patience needed with this rollercoaster!

User Image nesanmano Posted - 4 months ago

$CCXI lost around 3 k

User Image nesanmano Posted - 4 months ago

$CCXI fuck got sold out before that big news.

User Image marked0ne Posted - 4 months ago

@Kingjake26 @Stocktor $CCXI gang here ✌️

User Image Kingjake26 Posted - 4 months ago

$VRNA still down 22% for the year. We just got FDA approval for a possible multi billion dollar revenue opportunity. Plus they have alot of cash and ready to launch. Management knows what they are doing. I believe this is a long term opportunity just like our $CCXI was. I believe we will get better prices than we did with CCXi at $52 for a buyout with CCXi.

User Image Kingjake26 Posted - 4 months ago

$VRNA Hope everyone has a great 4th of July weekend. Be safe and enjoy family as much as you can. Very excited to be here with a ton of fellow $CCXI family God Bless!

User Image Ohzipit Posted - 4 months ago

This team $VKTX @$11, $RNA @$5, $MIRM under $20 $CCXI and $CBAY both recent buyouts…I would say more often than most!

User Image FastMonte Posted - 4 months ago

$SAVA Gonna ride this one like I did $CCXI. Shorts hit pieces dropped it to down $10 then a nice ride to a $52 buyout. Not worried at all here.

User Image TPapreee Posted - 06/27/24

$CCXI $VRNA

User Image Kingjake26 Posted - 06/27/24

$CCXI $VRNA just had to share one time. :)).

Analyst Ratings
Stifel Hold Aug 10, 22
SVB Leerink Market Perform Aug 5, 22
HC Wainwright & Co. Neutral Aug 5, 22
Canaccord Genuity Hold Aug 5, 22
Raymond James Market Perform Aug 5, 22
Raymond James Strong Buy May 6, 22
Raymond James Strong Buy Nov 10, 21
JP Morgan Neutral Oct 11, 21
SVB Leerink Outperform Oct 11, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Schall Thomas J. President and CEO President and CEO Aug 04 Option 14.28 130,000 1,856,400 2,523,352 08/08/22
Schall Thomas J. President and CEO President and CEO Aug 04 Sell 50.24 130,000 6,531,200 2,393,352 08/08/22
KANAYA SUSAN M EVP, CFO and Sec. EVP, CFO and Sec. Aug 04 Option 6.43 46,298 297,696 137,615 08/08/22
KANAYA SUSAN M EVP, CFO and Sec. EVP, CFO and Sec. Aug 04 Sell 50.17 46,298 2,322,771 91,317 08/08/22
Tyree James L Director Director Aug 04 Sell 50.22 10,000 502,200 9,138 08/08/22
Cappel Markus J. Chief Bus. Officer &.. Chief Bus. Officer & Treasurer Aug 04 Sell 50.22 7,564 379,864 87,658 08/08/22
Tyree James L Director Director Jun 09 Sell 25.94 3,863 100,206 19,138 06/13/22
Tyree James L Director Director May 20 Option 0.00 7,726 23,001 05/24/22
Parker Geoffrey M. Director Director May 20 Option 0.00 7,726 21,076 05/24/22
MCKINNELL HENRY A Director Director May 20 Option 0.00 7,726 72,749 05/24/22
Jain Rita EVP, Chief Medical O.. EVP, Chief Medical Officer May 20 Option 0.00 7,726 35,863 05/24/22
Parker Geoffrey M. Director Director May 02 Option 14.42 12,500 180,250 124,413 05/03/22
Jain Rita EVP, Chief Medical O.. EVP, Chief Medical Officer Mar 27 Option 0.00 5,251 28,137 03/29/22
FECZKO JOSEPH M Director Director Jan 21 Option 15.16 37,500 568,500 148,127 01/25/22
Tyree James L Director Director Dec 17 Option 13.52 37,500 507,000 52,775 12/21/21
Tyree James L Director Director Dec 17 Sell 34.59 37,500 1,297,125 15,275 12/21/21
Schall Thomas J. President and CEO President and CEO Dec 01 Option 12.29 45,936 564,553 2,354,816 12/03/21
Tyree James L Director Director May 24 Option 0 4,660 17,729 05/24/21
Parker Geoffrey M. Director Director Mar 08 Sell 57.62 31,910 1,838,654 12,690 03/08/21
Cappel Markus J. Chief Bus. Officer &.. Chief Bus. Officer & Treasurer Mar 03 Option 9.5 33,092 314,374 118,918 03/03/21
Cappel Markus J. Chief Bus. Officer &.. Chief Bus. Officer & Treasurer Mar 03 Sell 68.43 33,092 2,264,486 85,826 03/03/21
Edwards Thomas A. Director Director Mar 03 Sell 70.06 1,100 77,066 119,857 03/03/21
Kwan Pui San Principal Acctg Offi.. Principal Acctg Officer Mar 01 Option 10.31 3,347 34,508 6,579 03/01/21
Kwan Pui San Principal Acctg Offi.. Principal Acctg Officer Mar 01 Sell 68.49 3,347 229,236 3,232 03/01/21
Cappel Markus J. Chief Bus. Officer &.. Chief Bus. Officer & Treasurer Feb 11 Option 11.02 700 7,714 86,526 02/11/21
Cappel Markus J. Chief Bus. Officer &.. Chief Bus. Officer & Treasurer Feb 11 Sell 69.66 700 48,762 85,826 02/11/21
Cappel Markus J. Chief Bus. Officer &.. Chief Bus. Officer & Treasurer Feb 08 Option 11.02 9,625 106,068 93,246 02/08/21
Cappel Markus J. Chief Bus. Officer &.. Chief Bus. Officer & Treasurer Feb 08 Sell 67.37 9,625 648,436 85,826 02/08/21
Kwan Pui San Principal Acctg Offi.. Principal Acctg Officer Feb 08 Sell 65 3,347 217,555 3,232 02/08/21
Kwan Pui San Principal Acctg Offi.. Principal Acctg Officer Feb 08 Option 10.31 3,347 34,508 6,579 02/08/21
Edwards Thomas A. Director Director Feb 04 Sell 61 20,000 1,220,000 121,357 02/04/21
Cappel Markus J. Chief Bus. Officer &.. Chief Bus. Officer & Treasurer Jan 27 Option 11.02 1,375 15,152 87,201 01/27/21
Cappel Markus J. Chief Bus. Officer &.. Chief Bus. Officer & Treasurer Jan 27 Sell 67.03 1,375 92,166 85,826 01/27/21
Edwards Thomas A. Director Director Dec 29 Sell 61.34 25,000 1,533,500 141,357 12/29/20
Schall Thomas J. President and CEO President and CEO Dec 16 Option 14.31 28,772 411,727 2,286,176 12/16/20
Schall Thomas J. President and CEO President and CEO Dec 16 Sell 65.02 28,772 1,870,755 2,268,557 12/16/20
Kwan Pui San Principal Acctg Offi.. Principal Acctg Officer Dec 16 Option 8.39 51,550 432,505 45,825 12/16/20
Kwan Pui San Principal Acctg Offi.. Principal Acctg Officer Dec 16 Sell 65.04 51,550 3,352,812 3,232 12/16/20